MAPRE1 and cardiac arrhythmia: Previous studies have shown that EB1 reduction in myocardial IDs of heart failure patients is accompanied by a decrease in Cx43 in gap junctions (Smyth et al., 2010), suggesting that EB1 may be a biological target for improving Cx43 distribution and predicting arrhythmia.